Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept in Well-Controlled Myasthenia Gravis
NCT00408213Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2004
- Countries
- 7
01
Overview
A Phase 3 trial of mycophenolate mofetil in myasthenia gravis (MG), sponsored by Roche. Started Jun 2004; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00408213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408213.